Updated:
Pacific Biomarkers / NEOMED-LABS
The family behind Pacific Biomarkers and NEOMED-LABS built wealth through clinical laboratory services, establishing Pacific Biomarkers as a central lab...
Pacific Biomarkers / NEOMED-LABS
The family behind Pacific Biomarkers and NEOMED-LABS built wealth through clinical laboratory services, establishing Pacific Biomarkers as a central lab for clinical trials and NEOMED-LABS as a diagnostic testing network. The office, based in Seattle, manages this capital with a focus on healthcare services, diagnostics, and life sciences infrastructure. The investment strategy targets direct ownership of diagnostic laboratories and related healthcare services. The office holds controlling interests in Pacific Biomarkers and NEOMED-LABS, both of which operate as laboratory platforms. This self-owned model allows the office to invest in laboratory expansion, assay development, and testing capacity rather than external fund structures. The geographic focus is primarily North America, with laboratory operations serving clinical trial sponsors and healthcare providers. Team size and total deployment are not publicly disclosed. The office may maintain philanthropic structures in the healthcare space, though no formal foundation is on record. No recent operational event in the last 24 months has been publicly reported. The office's structural differentiator lies in its vertically integrated model: it does not just allocate capital to healthcare but owns the operating laboratory businesses themselves. This gives the office direct control over clinical testing platforms and an income stream from lab services, unlike a typical family office that relies on external fund managers.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Seattle
Corporate office
Seattle, WA, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Pacific Biomarkers / NEOMED-LABS?
The principals of the family office are not publicly named. Investment decisions are likely made by the founding family or senior management of the laboratory operations. No external CIO or investment team has been disclosed.
Is the wealth behind this family office tied to Pacific Biomarkers or NEOMED-LABS?
Yes, the wealth originates from the clinical laboratory businesses, specifically Pacific Biomarkers, a central lab for clinical trials, and NEOMED-LABS, a diagnostic testing network. The family office directly owns and operates these entities.
What investment strategy does this family office follow?
The office appears to focus on direct ownership of laboratory and healthcare service assets. It does not publicly disclose fund commitments or external investments; instead, it likely reinvests in expanding its own diagnostic and laboratory infrastructure.
What sectors does this family office invest in?
The office's known focus is healthcare services, specifically clinical diagnostics, laboratory testing for clinical trials, and life sciences infrastructure. No other sectors have been publicly identified.
Does this family office operate as a single family office or a multi-family office?
Based on the concentration of ownership in two specific laboratory entities, it is structured as a single family office managing wealth generated by the families behind Pacific Biomarkers and NEOMED-LABS. There is no evidence it serves external families.
Where is this family office located?
The headquarters is in Seattle, Washington, United States. No additional offices have been disclosed.
Has the firm made any recent public investments or announcements?
No recent public investment activity or announcements from the family office have been identified in the last 24 months. The laboratory operating entities may have made announcements, but the investment office itself remains private.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: